Article: Amsterdam Molecular Therapeutics Announces Pricing of Initial Public Offering (IPO) on Euronext Amsterdam.

AMSTERDAM, Netherlands -- NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

Highlights

* Offer price of EU10.00 per share

* Issue of 5,000,000 new ordinary shares

* Trading on Eurolist by Euronext expected to commence today as of 11:00 a.m. Amsterdam time

Introduction

Amsterdam Molecular Therapeutics (AMT) Holding B.V. (to be converted today into a public company with limited liability, Amsterdam Molecular Therapeutics (AMT) Holding N.V.) ("AMT"), a Dutch company active in the field of human gene therapy, announces today that it shall issue 5,000,000 new ordinary ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!